chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Troponin increased, Vomiting
Clinical narrative: 3 days after the 2nd dose of the Pfizer vaccine was administered, patient began to feel ill with a sore throat, body aches, swollen lymph nodes in the throat, and headache. He did not improve the next day or at all through the 4th day of having these symptoms. On the fifth day (Friday) he woke up with a fever (102 degrees). Mom took him to the pediatrician where they did an exam and a strep culture (it came back negative). The doctor sent patient home with orders to rest and drink fluids. The next day (Saturday), mom took patient to the local urgent care center to get a Covid test. There, they performed another exam, another strep culture and both rapid and lab Covid tests. All came back negative. He was prescribed and began antibiotics in case the sore throat was indeed strep. That same day, patient complained of his chest hurting and feeling tight. Sunday, he woke up with pronounced chest pain and said his left arm hurt. We thought it might be trapped gas and worked to get it out. He finally tired and slept but woke up complaining about the same chest pain and tightness. Again he tired to burp and move his body to release what we thought was trapped gas and again went to sleep. He woke up around midnight with severe chest pain radiating down his left arm. Mom took him to Emergency room where he was examined and questioned and later transferred to the other Hospital where he was admitted Monday morning to the pediatric cardiac ICU. It was determined that he was experiencing an acute myocarditis of unknown etiology.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chest discomfort, Chest pain, Echocardiogram, Electrocardiogram
Clinical narrative: 3 days after the 2nd dose of the Pfizer vaccine was administered, patient began to feel ill with a sore throat, body aches, swollen lymph nodes in the throat, and headache. He did not improve the next day or at all through the 4th day of having these symptoms. On the fifth day (Friday) he woke up with a fever (102 degrees). Mom took him to the pediatrician where they did an exam and a strep culture (it came back negative). The doctor sent patient home with orders to rest and drink fluids. The next day (Saturday), mom took patient to the local urgent care center to get a Covid test. There, they performed another exam, another strep culture and both rapid and lab Covid tests. All came back negative. He was prescribed and began antibiotics in case the sore throat was indeed strep. That same day, patient complained of his chest hurting and feeling tight. Sunday, he woke up with pronounced chest pain and said his left arm hurt. We thought it might be trapped gas and worked to get it out. He finally tired and slept but woke up complaining about the same chest pain and tightness. Again he tired to burp and move his body to release what we thought was trapped gas and again went to sleep. He woke up around midnight with severe chest pain radiating down his left arm. Mom took him to Emergency room where he was examined and questioned and later transferred to the other Hospital where he was admitted Monday morning to the pediatric cardiac ICU. It was determined that he was experiencing an acute myocarditis of unknown etiology.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Epstein-Barr virus antibody negative, Headache, Immunology test, Intensive care, Lymphadenopathy
Clinical narrative: 3 days after the 2nd dose of the Pfizer vaccine was administered, patient began to feel ill with a sore throat, body aches, swollen lymph nodes in the throat, and headache. He did not improve the next day or at all through the 4th day of having these symptoms. On the fifth day (Friday) he woke up with a fever (102 degrees). Mom took him to the pediatrician where they did an exam and a strep culture (it came back negative). The doctor sent patient home with orders to rest and drink fluids. The next day (Saturday), mom took patient to the local urgent care center to get a Covid test. There, they performed another exam, another strep culture and both rapid and lab Covid tests. All came back negative. He was prescribed and began antibiotics in case the sore throat was indeed strep. That same day, patient complained of his chest hurting and feeling tight. Sunday, he woke up with pronounced chest pain and said his left arm hurt. We thought it might be trapped gas and worked to get it out. He finally tired and slept but woke up complaining about the same chest pain and tightness. Again he tired to burp and move his body to release what we thought was trapped gas and again went to sleep. He woke up around midnight with severe chest pain radiating down his left arm. Mom took him to Emergency room where he was examined and questioned and later transferred to the other Hospital where he was admitted Monday morning to the pediatric cardiac ICU. It was determined that he was experiencing an acute myocarditis of unknown etiology.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, Myocarditis, Oropharyngeal pain, Pain, Pain in extremity
Clinical narrative: 3 days after the 2nd dose of the Pfizer vaccine was administered, patient began to feel ill with a sore throat, body aches, swollen lymph nodes in the throat, and headache. He did not improve the next day or at all through the 4th day of having these symptoms. On the fifth day (Friday) he woke up with a fever (102 degrees). Mom took him to the pediatrician where they did an exam and a strep culture (it came back negative). The doctor sent patient home with orders to rest and drink fluids. The next day (Saturday), mom took patient to the local urgent care center to get a Covid test. There, they performed another exam, another strep culture and both rapid and lab Covid tests. All came back negative. He was prescribed and began antibiotics in case the sore throat was indeed strep. That same day, patient complained of his chest hurting and feeling tight. Sunday, he woke up with pronounced chest pain and said his left arm hurt. We thought it might be trapped gas and worked to get it out. He finally tired and slept but woke up complaining about the same chest pain and tightness. Again he tired to burp and move his body to release what we thought was trapped gas and again went to sleep. He woke up around midnight with severe chest pain radiating down his left arm. Mom took him to Emergency room where he was examined and questioned and later transferred to the other Hospital where he was admitted Monday morning to the pediatric cardiac ICU. It was determined that he was experiencing an acute myocarditis of unknown etiology.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative, Troponin increased
Clinical narrative: 3 days after the 2nd dose of the Pfizer vaccine was administered, patient began to feel ill with a sore throat, body aches, swollen lymph nodes in the throat, and headache. He did not improve the next day or at all through the 4th day of having these symptoms. On the fifth day (Friday) he woke up with a fever (102 degrees). Mom took him to the pediatrician where they did an exam and a strep culture (it came back negative). The doctor sent patient home with orders to rest and drink fluids. The next day (Saturday), mom took patient to the local urgent care center to get a Covid test. There, they performed another exam, another strep culture and both rapid and lab Covid tests. All came back negative. He was prescribed and began antibiotics in case the sore throat was indeed strep. That same day, patient complained of his chest hurting and feeling tight. Sunday, he woke up with pronounced chest pain and said his left arm hurt. We thought it might be trapped gas and worked to get it out. He finally tired and slept but woke up complaining about the same chest pain and tightness. Again he tired to burp and move his body to release what we thought was trapped gas and again went to sleep. He woke up around midnight with severe chest pain radiating down his left arm. Mom took him to Emergency room where he was examined and questioned and later transferred to the other Hospital where he was admitted Monday morning to the pediatric cardiac ICU. It was determined that he was experiencing an acute myocarditis of unknown etiology.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Ear infection, Tinnitus
Clinical narrative: My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; ringing will decrease, increase and will even become muffled; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), dose 2 via an unspecified route of administration in left arm on 28Mar2021 09:00 (at the age of 30-years-old ) as second dose, single for COVID-19 immunization. Medical history included known allergies. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198) via an unspecified route of administration in left arm on 07Mar2021 08:45 as first dose, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient received some other medications within two weeks prior to vaccination.   On 05Apr2021, the patient's ears began to pop, hurt, and itch then started ringing intermittently within a week of taking the second COVID-19 dose. Shortly thereafter, they began to ring continuously and hadn't stopped. Sometimes the ringing will decrease, increase and will even become muffled and things will sound like she was under water. She had been seen at urgent care twice for this issue and now scheduled to see an ENT on 20May2021 at 3:15PM. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on an unspecified date, post vaccination. Events were treated with two rounds of antibiotics. Outcome of the events were not resolved.   Information on the lot/batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Ear pain, Ear pruritus, Hypoacusis, SARS-CoV-2 test
Clinical narrative: My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; ringing will decrease, increase and will even become muffled; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), dose 2 via an unspecified route of administration in left arm on 28Mar2021 09:00 (at the age of 30-years-old ) as second dose, single for COVID-19 immunization. Medical history included known allergies. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198) via an unspecified route of administration in left arm on 07Mar2021 08:45 as first dose, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient received some other medications within two weeks prior to vaccination.   On 05Apr2021, the patient's ears began to pop, hurt, and itch then started ringing intermittently within a week of taking the second COVID-19 dose. Shortly thereafter, they began to ring continuously and hadn't stopped. Sometimes the ringing will decrease, increase and will even become muffled and things will sound like she was under water. She had been seen at urgent care twice for this issue and now scheduled to see an ENT on 20May2021 at 3:15PM. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on an unspecified date, post vaccination. Events were treated with two rounds of antibiotics. Outcome of the events were not resolved.   Information on the lot/batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; My ears began to pop, hurt, and itch then started ringing; ringing will decrease, increase and will even become muffled; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), dose 2 via an unspecified route of administration in left arm on 28Mar2021 09:00 (at the age of 30-years-old ) as second dose, single for COVID-19 immunization. Medical history included known allergies. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198) via an unspecified route of administration in left arm on 07Mar2021 08:45 as first dose, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient received some other medications within two weeks prior to vaccination.   On 05Apr2021, the patient's ears began to pop, hurt, and itch then started ringing intermittently within a week of taking the second COVID-19 dose. Shortly thereafter, they began to ring continuously and hadn't stopped. Sometimes the ringing will decrease, increase and will even become muffled and things will sound like she was under water. She had been seen at urgent care twice for this issue and now scheduled to see an ENT on 20May2021 at 3:15PM. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on an unspecified date, post vaccination. Events were treated with two rounds of antibiotics. Outcome of the events were not resolved.   Information on the lot/batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Extensive swelling of vaccinated limb
Clinical narrative: Redness, pain and swelling on the area of injection and radiated to all the arm up to the hand.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: Redness, pain and swelling on the area of injection and radiated to all the arm up to the hand.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Redness, pain and swelling on the area of injection and radiated to all the arm up to the hand.
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, SARS-CoV-2 test negative, Vomiting
Clinical narrative: Nausea; vomiting; This is a spontaneous report from a contactable physician. A 14-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0182), dose 1 via an unspecified route of administration on 14May2021 (at the age of 14-years-old ) as first dose, singe for COVID-19 immunization. Medical history included gluten allergy. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient experienced nausea and vomiting on 17May2021 11:00. Since the vaccination, patient has not been tested for COVID-19. The events resulted in physician or other healthcare professional office/clinic visit and was treated with oral Ondansetron. Outcome of the events were resolved.
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Nausea; vomiting; This is a spontaneous report from a contactable physician. A 14-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0182), dose 1 via an unspecified route of administration on 14May2021 (at the age of 14-years-old ) as first dose, singe for COVID-19 immunization. Medical history included gluten allergy. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient experienced nausea and vomiting on 17May2021 11:00. Since the vaccination, patient has not been tested for COVID-19. The events resulted in physician or other healthcare professional office/clinic visit and was treated with oral Ondansetron. Outcome of the events were resolved.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: Swollen tongue and metallic taste; Swollen tongue and metallic taste; This is a spontaneous report from a contactable HCP (patient). A 45-year-old female (no pregnant) patient received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 18May2021 at 09:45 (Lot Number: 59267100001) as single dose for COVID-19 immunization. Relevant medical history and concurrent conditions included seasonal allergies-asthma. Known allergies is sulfas. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included fexofenadine hydrochloride (ALLEGRA). The patient experienced swollen tongue and metallic taste on 18May2021 at 10:45. The adverse event result in doctor or other HCP office/clinic visit. The steroids had been received as treatment for the adverse events. The outcome of events was recovered on an unspecified date.  No attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Swollen tongue
Clinical narrative: Swollen tongue and metallic taste; Swollen tongue and metallic taste; This is a spontaneous report from a contactable HCP (patient). A 45-year-old female (no pregnant) patient received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 18May2021 at 09:45 (Lot Number: 59267100001) as single dose for COVID-19 immunization. Relevant medical history and concurrent conditions included seasonal allergies-asthma. Known allergies is sulfas. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included fexofenadine hydrochloride (ALLEGRA). The patient experienced swollen tongue and metallic taste on 18May2021 at 10:45. The adverse event result in doctor or other HCP office/clinic visit. The steroids had been received as treatment for the adverse events. The outcome of events was recovered on an unspecified date.  No attempts are possible. No further information is expected.
Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Pruritus
Clinical narrative: Pt got the COVID vaccine, felt sore right away and itchy all over -itchiness on right arm and left arm and then felt chest tightness and shortness of breath. Was monitored in ED and treated with benadryl, pepcid and then course of prednisone x 5 days. She seems better today but still having lower energy than normal. No vomiting or hives. She felt itchy on right arm, no rash.. Took some benadryl for this. She had COVID last November.
Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chest discomfort, Dyspnoea, Pain, Pruritus
Clinical narrative: Pt got the COVID vaccine, felt sore right away and itchy all over -itchiness on right arm and left arm and then felt chest tightness and shortness of breath. Was monitored in ED and treated with benadryl, pepcid and then course of prednisone x 5 days. She seems better today but still having lower energy than normal. No vomiting or hives. She felt itchy on right arm, no rash.. Took some benadryl for this. She had COVID last November.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arteriogram coronary normal, Cardiac failure, Cardiac imaging procedure abnormal, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: HPI/Subjective:  is a  47 year old male with minimal past medical history who presents in consultation. He was hospitalized  with myocarditis. The patient presented to PWF 5/16 with CP, fatigue and elevated HR.  He had received his second dose of the Moderna COVID-19 vaccine 3 days prior. The initial ECG showed nonspecific ST abnormalities. HS-troponin 1,438 -- > 5,951.  Echo showed ejection fraction of 35% with global hypokinesis, akinesis in inferior and inferoapical segments, and mild right ventricular hypokinesis. He was subsequently transferred to to PPMC and underwent coronary angiogram on 5/18/21 which demonstrated normal coronary arteries. In consultation with Dr. , he was discharged on losartan 25 mg/day and metoprolol succinate 50 mg BID for outpatient follow-up.    Cardiac MRI 5/19 showed T2 signal abnormality and LGE involving the subepicardium of the lateral wall, inferior wall, as well as septum c/w acute myocarditis. LVEF 53%.   Dr. submitted his case to the VAERS site.   reports feeling much improved. He denies fatigue, dyspnea, palpitation, or presyncope. He has noted fleeting chest discomfort. No fevers or chills.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging heart, Myocarditis, N-terminal prohormone brain natriuretic peptide increased, Troponin increased, Wall motion score index abnormal
Clinical narrative: HPI/Subjective:  is a  47 year old male with minimal past medical history who presents in consultation. He was hospitalized  with myocarditis. The patient presented to PWF 5/16 with CP, fatigue and elevated HR.  He had received his second dose of the Moderna COVID-19 vaccine 3 days prior. The initial ECG showed nonspecific ST abnormalities. HS-troponin 1,438 -- > 5,951.  Echo showed ejection fraction of 35% with global hypokinesis, akinesis in inferior and inferoapical segments, and mild right ventricular hypokinesis. He was subsequently transferred to to PPMC and underwent coronary angiogram on 5/18/21 which demonstrated normal coronary arteries. In consultation with Dr. , he was discharged on losartan 25 mg/day and metoprolol succinate 50 mg BID for outpatient follow-up.    Cardiac MRI 5/19 showed T2 signal abnormality and LGE involving the subepicardium of the lateral wall, inferior wall, as well as septum c/w acute myocarditis. LVEF 53%.   Dr. submitted his case to the VAERS site.   reports feeling much improved. He denies fatigue, dyspnea, palpitation, or presyncope. He has noted fleeting chest discomfort. No fevers or chills.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Akinesia, Angiocardiogram, Chest discomfort, Chest pain, Echocardiogram abnormal
Clinical narrative: HPI/Subjective:  is a  47 year old male with minimal past medical history who presents in consultation. He was hospitalized  with myocarditis. The patient presented to PWF 5/16 with CP, fatigue and elevated HR.  He had received his second dose of the Moderna COVID-19 vaccine 3 days prior. The initial ECG showed nonspecific ST abnormalities. HS-troponin 1,438 -- > 5,951.  Echo showed ejection fraction of 35% with global hypokinesis, akinesis in inferior and inferoapical segments, and mild right ventricular hypokinesis. He was subsequently transferred to to PPMC and underwent coronary angiogram on 5/18/21 which demonstrated normal coronary arteries. In consultation with Dr. , he was discharged on losartan 25 mg/day and metoprolol succinate 50 mg BID for outpatient follow-up.    Cardiac MRI 5/19 showed T2 signal abnormality and LGE involving the subepicardium of the lateral wall, inferior wall, as well as septum c/w acute myocarditis. LVEF 53%.   Dr. submitted his case to the VAERS site.   reports feeling much improved. He denies fatigue, dyspnea, palpitation, or presyncope. He has noted fleeting chest discomfort. No fevers or chills.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Ejection fraction decreased, Electrocardiogram ST segment abnormal, Electrocardiogram abnormal, Fatigue, Gingival erythema
Clinical narrative: HPI/Subjective:  is a  47 year old male with minimal past medical history who presents in consultation. He was hospitalized  with myocarditis. The patient presented to PWF 5/16 with CP, fatigue and elevated HR.  He had received his second dose of the Moderna COVID-19 vaccine 3 days prior. The initial ECG showed nonspecific ST abnormalities. HS-troponin 1,438 -- > 5,951.  Echo showed ejection fraction of 35% with global hypokinesis, akinesis in inferior and inferoapical segments, and mild right ventricular hypokinesis. He was subsequently transferred to to PPMC and underwent coronary angiogram on 5/18/21 which demonstrated normal coronary arteries. In consultation with Dr. , he was discharged on losartan 25 mg/day and metoprolol succinate 50 mg BID for outpatient follow-up.    Cardiac MRI 5/19 showed T2 signal abnormality and LGE involving the subepicardium of the lateral wall, inferior wall, as well as septum c/w acute myocarditis. LVEF 53%.   Dr. submitted his case to the VAERS site.   reports feeling much improved. He denies fatigue, dyspnea, palpitation, or presyncope. He has noted fleeting chest discomfort. No fevers or chills.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Heart rate increased, Magnetic resonance imaging heart, Myocarditis, Troponin increased, Ventricular hypokinesia
Clinical narrative: HPI/Subjective:  is a  47 year old male with minimal past medical history who presents in consultation. He was hospitalized  with myocarditis. The patient presented to PWF 5/16 with CP, fatigue and elevated HR.  He had received his second dose of the Moderna COVID-19 vaccine 3 days prior. The initial ECG showed nonspecific ST abnormalities. HS-troponin 1,438 -- > 5,951.  Echo showed ejection fraction of 35% with global hypokinesis, akinesis in inferior and inferoapical segments, and mild right ventricular hypokinesis. He was subsequently transferred to to PPMC and underwent coronary angiogram on 5/18/21 which demonstrated normal coronary arteries. In consultation with Dr. , he was discharged on losartan 25 mg/day and metoprolol succinate 50 mg BID for outpatient follow-up.    Cardiac MRI 5/19 showed T2 signal abnormality and LGE involving the subepicardium of the lateral wall, inferior wall, as well as septum c/w acute myocarditis. LVEF 53%.   Dr. submitted his case to the VAERS site.   reports feeling much improved. He denies fatigue, dyspnea, palpitation, or presyncope. He has noted fleeting chest discomfort. No fevers or chills.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arteriogram coronary normal, Brain natriuretic peptide increased, Cardiac imaging procedure abnormal, Chest X-ray normal, Chest pain
Clinical narrative: HPI/Subjective:  is a  47 year old male with minimal past medical history who presents in consultation. He was hospitalized  with myocarditis. The patient presented to PWF 5/16 with CP, fatigue and elevated HR.  He had received his second dose of the Moderna COVID-19 vaccine 3 days prior. The initial ECG showed nonspecific ST abnormalities. HS-troponin 1,438 -- > 5,951.  Echo showed ejection fraction of 35% with global hypokinesis, akinesis in inferior and inferoapical segments, and mild right ventricular hypokinesis. He was subsequently transferred to to PPMC and underwent coronary angiogram on 5/18/21 which demonstrated normal coronary arteries. In consultation with Dr. , he was discharged on losartan 25 mg/day and metoprolol succinate 50 mg BID for outpatient follow-up.    Cardiac MRI 5/19 showed T2 signal abnormality and LGE involving the subepicardium of the lateral wall, inferior wall, as well as septum c/w acute myocarditis. LVEF 53%.   Dr. submitted his case to the VAERS site.   reports feeling much improved. He denies fatigue, dyspnea, palpitation, or presyncope. He has noted fleeting chest discomfort. No fevers or chills.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Magnetic resonance imaging head abnormal, Magnetic resonance imaging heart, Malaise
Clinical narrative: HPI/Subjective:  is a  47 year old male with minimal past medical history who presents in consultation. He was hospitalized  with myocarditis. The patient presented to PWF 5/16 with CP, fatigue and elevated HR.  He had received his second dose of the Moderna COVID-19 vaccine 3 days prior. The initial ECG showed nonspecific ST abnormalities. HS-troponin 1,438 -- > 5,951.  Echo showed ejection fraction of 35% with global hypokinesis, akinesis in inferior and inferoapical segments, and mild right ventricular hypokinesis. He was subsequently transferred to to PPMC and underwent coronary angiogram on 5/18/21 which demonstrated normal coronary arteries. In consultation with Dr. , he was discharged on losartan 25 mg/day and metoprolol succinate 50 mg BID for outpatient follow-up.    Cardiac MRI 5/19 showed T2 signal abnormality and LGE involving the subepicardium of the lateral wall, inferior wall, as well as septum c/w acute myocarditis. LVEF 53%.   Dr. submitted his case to the VAERS site.   reports feeling much improved. He denies fatigue, dyspnea, palpitation, or presyncope. He has noted fleeting chest discomfort. No fevers or chills.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Myocarditis, Troponin increased, Ventricular hypokinesia
Clinical narrative: HPI/Subjective:  is a  47 year old male with minimal past medical history who presents in consultation. He was hospitalized  with myocarditis. The patient presented to PWF 5/16 with CP, fatigue and elevated HR.  He had received his second dose of the Moderna COVID-19 vaccine 3 days prior. The initial ECG showed nonspecific ST abnormalities. HS-troponin 1,438 -- > 5,951.  Echo showed ejection fraction of 35% with global hypokinesis, akinesis in inferior and inferoapical segments, and mild right ventricular hypokinesis. He was subsequently transferred to to PPMC and underwent coronary angiogram on 5/18/21 which demonstrated normal coronary arteries. In consultation with Dr. , he was discharged on losartan 25 mg/day and metoprolol succinate 50 mg BID for outpatient follow-up.    Cardiac MRI 5/19 showed T2 signal abnormality and LGE involving the subepicardium of the lateral wall, inferior wall, as well as septum c/w acute myocarditis. LVEF 53%.   Dr. submitted his case to the VAERS site.   reports feeling much improved. He denies fatigue, dyspnea, palpitation, or presyncope. He has noted fleeting chest discomfort. No fevers or chills.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dysphonia, Periorbital swelling, Swollen tongue
Clinical narrative: Pt reported an anaphylactic history to bee stings with his last reaction being in 2017 during his screening. Pt was instructed to wait an additional 30 minutes following his vaccination. Pt was given his vaccine at 1134. Pt reported a sensation of "tongue swelling and chest tightness" at 1139. Pt reported it felt like his past anaphylactic reaction. Pt voice sounded muffled, tongue appeared swollen. Pt self administered 1 adult Epi Pen at 1139 with x1 RN and x1 medic supervision. VS were taken. HR was 107, BP was 137/92, SpO2 was 97%. Lung sounds were clear in the apices and diminished in the bases bilaterally. Periorbital swelling was noted at 1140. 911 was called and an ambulance was dispatched at this time. The pt denied a feeling of nausea, denied dizziness. Pt was alert and oriented x4/4 for the entirety of observation. VS were taken again at 1144. The HR was 97, BP was 131/85, SpO2 was 97%. Last reported oral intake of a "bagel and coffee at 0800". VS taken again at 1147, HR 101, BP 135/86, SpO2 98%. Pt reported a continued feeling of throat tightness, periorbital swelling was increasing. Ambulance arrived at 1154 and was given full report. Paramedic assumed care at 1155. Paramedic team deemed it safe to administer one more dose of epinephrine and transport patient via ambulance to ER. In ER, patient endorses mild chest tightness but denies any shortness of breath, oral pharyngeal edema, difficulty swallowing, wheezing, abdominal discomfort, nausea or vomiting, pruritus, or hives.  He was given Benadryl, methylprednisolone, and famotidine while in the emergency department to finish the allergic reaction cocktail.  He was observed for a total of 3 hours after his last epi injection and he remained HDS and asymptomatic.  He was given a prescription for EpiPen autoinjectors with multiple refills.  Patient was advised that he should not receive his second covered vaccination without discussing with his PCM.  He was given strict return precautions and patient felt comfortable being discharged home.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dysphonia, Periorbital swelling, Swollen tongue, Throat tightness
Clinical narrative: Pt reported an anaphylactic history to bee stings with his last reaction being in 2017 during his screening. Pt was instructed to wait an additional 30 minutes following his vaccination. Pt was given his vaccine at 1134. Pt reported a sensation of "tongue swelling and chest tightness" at 1139. Pt reported it felt like his past anaphylactic reaction. Pt voice sounded muffled, tongue appeared swollen. Pt self administered 1 adult Epi Pen at 1139 with x1 RN and x1 medic supervision. VS were taken. HR was 107, BP was 137/92, SpO2 was 97%. Lung sounds were clear in the apices and diminished in the bases bilaterally. Periorbital swelling was noted at 1140. 911 was called and an ambulance was dispatched at this time. The pt denied a feeling of nausea, denied dizziness. Pt was alert and oriented x4/4 for the entirety of observation. VS were taken again at 1144. The HR was 97, BP was 131/85, SpO2 was 97%. Last reported oral intake of a "bagel and coffee at 0800". VS taken again at 1147, HR 101, BP 135/86, SpO2 98%. Pt reported a continued feeling of throat tightness, periorbital swelling was increasing. Ambulance arrived at 1154 and was given full report. Paramedic assumed care at 1155. Paramedic team deemed it safe to administer one more dose of epinephrine and transport patient via ambulance to ER. In ER, patient endorses mild chest tightness but denies any shortness of breath, oral pharyngeal edema, difficulty swallowing, wheezing, abdominal discomfort, nausea or vomiting, pruritus, or hives.  He was given Benadryl, methylprednisolone, and famotidine while in the emergency department to finish the allergic reaction cocktail.  He was observed for a total of 3 hours after his last epi injection and he remained HDS and asymptomatic.  He was given a prescription for EpiPen autoinjectors with multiple refills.  Patient was advised that he should not receive his second covered vaccination without discussing with his PCM.  He was given strict return precautions and patient felt comfortable being discharged home.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: SISTER  IS GIVING THIS INFORMATION.....STATES CALLED PATIENT ON 02/15/2021 AND THAT THE PATIENT SAID SHE DIDN'T FEEL GOOD.  STATES THAT PT SOUNDED INCOHERENT AND WAS "NOT MAKING ALOT OF SENSE". PT SAID SHE WAS GOING TO BED.  SISTER WAS NOTIFIED ON 02/16/2021 THAT PT HAD BEEN FOUND IN THE FLOOR BY HER SON AND HAD PASSED AWAY.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Disorganised speech, Incoherent, Malaise
Clinical narrative: SISTER  IS GIVING THIS INFORMATION.....STATES CALLED PATIENT ON 02/15/2021 AND THAT THE PATIENT SAID SHE DIDN'T FEEL GOOD.  STATES THAT PT SOUNDED INCOHERENT AND WAS "NOT MAKING ALOT OF SENSE". PT SAID SHE WAS GOING TO BED.  SISTER WAS NOTIFIED ON 02/16/2021 THAT PT HAD BEEN FOUND IN THE FLOOR BY HER SON AND HAD PASSED AWAY.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Electrocardiogram abnormal, Fatigue
Clinical narrative: -Daily Headaches -nausea -Vomiting -Sweats -Chills -Body pain -dizziness -Shortness of breath -Extreme fatigue
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Hyperhidrosis, Impaired work ability, Malaise, Nausea
Clinical narrative: -Daily Headaches -nausea -Vomiting -Sweats -Chills -Body pain -dizziness -Shortness of breath -Extreme fatigue
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Vomiting
Clinical narrative: -Daily Headaches -nausea -Vomiting -Sweats -Chills -Body pain -dizziness -Shortness of breath -Extreme fatigue
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Electrocardiogram, Electrocardiogram abnormal
Clinical narrative: -Daily Headaches -nausea -Vomiting -Sweats -Chills -Body pain -dizziness -Shortness of breath -Extreme fatigue
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Nausea, Pain
Clinical narrative: -Daily Headaches -nausea -Vomiting -Sweats -Chills -Body pain -dizziness -Shortness of breath -Extreme fatigue
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Visual impairment, Vomiting
Clinical narrative: -Daily Headaches -nausea -Vomiting -Sweats -Chills -Body pain -dizziness -Shortness of breath -Extreme fatigue
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Fatigue, Headache
Clinical narrative: -Daily Headaches -nausea -Vomiting -Sweats -Chills -Body pain -dizziness -Shortness of breath -Extreme fatigue
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hyperhidrosis, Nausea, Pain, Vomiting
Clinical narrative: -Daily Headaches -nausea -Vomiting -Sweats -Chills -Body pain -dizziness -Shortness of breath -Extreme fatigue
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood electrolytes normal, Brain natriuretic peptide normal, C-reactive protein increased, Chest pain, Dyspnoea
Clinical narrative: chest pain 2 days after vaccine, Dx: myocarditis, confirmed by cardiac MRI
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Full blood count normal, Headache, Myocarditis, Pain
Clinical narrative: chest pain 2 days after vaccine, Dx: myocarditis, confirmed by cardiac MRI
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate normal, Troponin increased
Clinical narrative: chest pain 2 days after vaccine, Dx: myocarditis, confirmed by cardiac MRI
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac imaging procedure abnormal, Chest pain, Electrocardiogram abnormal, Magnetic resonance imaging heart, Myocarditis
Clinical narrative: chest pain 2 days after vaccine, Dx: myocarditis, confirmed by cardiac MRI
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: chest pain 2 days after vaccine, Dx: myocarditis, confirmed by cardiac MRI
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Chest discomfort, Dysphagia, Oropharyngeal discomfort, Pruritus
Clinical narrative: 5/25/2021: Patient checked in to Immunization for Pfizer Covid Vaccine Dose #1 (LOT EW0183 EXP 08/21) at 1254 then sent to observation area after vaccine administration.  Shortly after receiving the dose of Pfizer covid vaccine, patient had complaint of itchiness.  Observer went to notify Nurse. Nurse noted patient began to have trouble talking and difficulty swallowing and breathing.  EPIpen was immediately administered to Right Thigh (0FM500 exp May 22) at 1325.  Patient states she has history of Anaphylaxis with Influenza vaccine and a "list" of medications.  Patient then stated that immediately after receiving the COVID vaccine, when itchiness began she self-medicated with 25mg of Benadryl PO when she alerted the Observer of the itchiness.  Code was called at 1331 and transported to ED for further treatment and evaluation (via wheelchair as awake, alert and oriented).  Nurse from Immunizations went with Code team member to transport patient to ED when 2nd Epipen (0FM407 EXP FEB22) was administered with direction of MD in elevator after patient began having tightness in chest and grabbing throat.  Patient care transferred to ED.  Code cleared at 1348. 5/26/21: Follow up: This 53 yo stated within 5 min after yesterdays vaccination she was itching all over and felt hot and skin bumpy (rash).  She took a benadryl and told staff and they gave her total of 2 epi pens due to c/o hoarse thick feeling in throat, SOB, chest tightness, (states this reaction was much faster than past reactions to other medications).  Today she is doing well, no further itching, redness, tight throat, no SOB/CP and reports no fevers, HA, arthralgia, muscle aches or site irritation post vaccination.  She is continuing the 3 medications given on discharge (steroid, 2 antihistamines) and is drinking lots of water to flush her system.  She has family in the house with her.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Chest discomfort, Dysphagia, Dyspnoea, Feeling hot
Clinical narrative: 5/25/2021: Patient checked in to Immunization for Pfizer Covid Vaccine Dose #1 (LOT EW0183 EXP 08/21) at 1254 then sent to observation area after vaccine administration.  Shortly after receiving the dose of Pfizer covid vaccine, patient had complaint of itchiness.  Observer went to notify Nurse. Nurse noted patient began to have trouble talking and difficulty swallowing and breathing.  EPIpen was immediately administered to Right Thigh (0FM500 exp May 22) at 1325.  Patient states she has history of Anaphylaxis with Influenza vaccine and a "list" of medications.  Patient then stated that immediately after receiving the COVID vaccine, when itchiness began she self-medicated with 25mg of Benadryl PO when she alerted the Observer of the itchiness.  Code was called at 1331 and transported to ED for further treatment and evaluation (via wheelchair as awake, alert and oriented).  Nurse from Immunizations went with Code team member to transport patient to ED when 2nd Epipen (0FM407 EXP FEB22) was administered with direction of MD in elevator after patient began having tightness in chest and grabbing throat.  Patient care transferred to ED.  Code cleared at 1348. 5/26/21: Follow up: This 53 yo stated within 5 min after yesterdays vaccination she was itching all over and felt hot and skin bumpy (rash).  She took a benadryl and told staff and they gave her total of 2 epi pens due to c/o hoarse thick feeling in throat, SOB, chest tightness, (states this reaction was much faster than past reactions to other medications).  Today she is doing well, no further itching, redness, tight throat, no SOB/CP and reports no fevers, HA, arthralgia, muscle aches or site irritation post vaccination.  She is continuing the 3 medications given on discharge (steroid, 2 antihistamines) and is drinking lots of water to flush her system.  She has family in the house with her.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count normal, Immediate post-injection reaction, Metabolic function test normal, Oropharyngeal discomfort, Pruritus
Clinical narrative: 5/25/2021: Patient checked in to Immunization for Pfizer Covid Vaccine Dose #1 (LOT EW0183 EXP 08/21) at 1254 then sent to observation area after vaccine administration.  Shortly after receiving the dose of Pfizer covid vaccine, patient had complaint of itchiness.  Observer went to notify Nurse. Nurse noted patient began to have trouble talking and difficulty swallowing and breathing.  EPIpen was immediately administered to Right Thigh (0FM500 exp May 22) at 1325.  Patient states she has history of Anaphylaxis with Influenza vaccine and a "list" of medications.  Patient then stated that immediately after receiving the COVID vaccine, when itchiness began she self-medicated with 25mg of Benadryl PO when she alerted the Observer of the itchiness.  Code was called at 1331 and transported to ED for further treatment and evaluation (via wheelchair as awake, alert and oriented).  Nurse from Immunizations went with Code team member to transport patient to ED when 2nd Epipen (0FM407 EXP FEB22) was administered with direction of MD in elevator after patient began having tightness in chest and grabbing throat.  Patient care transferred to ED.  Code cleared at 1348. 5/26/21: Follow up: This 53 yo stated within 5 min after yesterdays vaccination she was itching all over and felt hot and skin bumpy (rash).  She took a benadryl and told staff and they gave her total of 2 epi pens due to c/o hoarse thick feeling in throat, SOB, chest tightness, (states this reaction was much faster than past reactions to other medications).  Today she is doing well, no further itching, redness, tight throat, no SOB/CP and reports no fevers, HA, arthralgia, muscle aches or site irritation post vaccination.  She is continuing the 3 medications given on discharge (steroid, 2 antihistamines) and is drinking lots of water to flush her system.  She has family in the house with her.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Throat tightness, Tryptase
Clinical narrative: 5/25/2021: Patient checked in to Immunization for Pfizer Covid Vaccine Dose #1 (LOT EW0183 EXP 08/21) at 1254 then sent to observation area after vaccine administration.  Shortly after receiving the dose of Pfizer covid vaccine, patient had complaint of itchiness.  Observer went to notify Nurse. Nurse noted patient began to have trouble talking and difficulty swallowing and breathing.  EPIpen was immediately administered to Right Thigh (0FM500 exp May 22) at 1325.  Patient states she has history of Anaphylaxis with Influenza vaccine and a "list" of medications.  Patient then stated that immediately after receiving the COVID vaccine, when itchiness began she self-medicated with 25mg of Benadryl PO when she alerted the Observer of the itchiness.  Code was called at 1331 and transported to ED for further treatment and evaluation (via wheelchair as awake, alert and oriented).  Nurse from Immunizations went with Code team member to transport patient to ED when 2nd Epipen (0FM407 EXP FEB22) was administered with direction of MD in elevator after patient began having tightness in chest and grabbing throat.  Patient care transferred to ED.  Code cleared at 1348. 5/26/21: Follow up: This 53 yo stated within 5 min after yesterdays vaccination she was itching all over and felt hot and skin bumpy (rash).  She took a benadryl and told staff and they gave her total of 2 epi pens due to c/o hoarse thick feeling in throat, SOB, chest tightness, (states this reaction was much faster than past reactions to other medications).  Today she is doing well, no further itching, redness, tight throat, no SOB/CP and reports no fevers, HA, arthralgia, muscle aches or site irritation post vaccination.  She is continuing the 3 medications given on discharge (steroid, 2 antihistamines) and is drinking lots of water to flush her system.  She has family in the house with her.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Borrelia test, Chest pain, Coxsackie virus test, Cytomegalovirus test, Echocardiogram
Clinical narrative: Pt presented with 2 days of chest pain in conjunction with the expected body aches, chills and fatigue after his second Pfizer vaccine. Found to have elevated troponin and diagnosed with myopericarditis. Treated with NSAIDs, colchicine. Had normal cardiac MRI and CTA coronary. Relatively preserved EF on echo (53%) with no focal wall motion abnormalities.
Age: 20.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Echovirus test, Ejection fraction decreased, Electrocardiogram ST segment elevation, Electrocardiogram abnormal, HIV antibody negative
Clinical narrative: Pt presented with 2 days of chest pain in conjunction with the expected body aches, chills and fatigue after his second Pfizer vaccine. Found to have elevated troponin and diagnosed with myopericarditis. Treated with NSAIDs, colchicine. Had normal cardiac MRI and CTA coronary. Relatively preserved EF on echo (53%) with no focal wall motion abnormalities.